MEDI1109

N/A

Report date: 2021/12/01 11:29:46

Base Information

Drug NameMEDI1109

Drug Alias NameMEDI-1109

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTumor necrosis factor receptor superfamily member 4 agonistsProgrammed death-ligand 1 blockers

TargetsTumor necrosis factor receptor superfamily member 4Programmed death-ligand 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMedimmune Llc

China Registration ClassN/A

Develop Information

Active CompaniesMedimmune Llc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A